Vaxart VXRT
OTC VXRT
$0.48 -0.01 (-1.94%)
As of: Oct 21, 2026 · 12:16 PM EDT

Vaxart (VXRT) Convertible Debt (2017)

Updated

Vaxart's Convertible Debt was $35.28 million in Q4 2017.

Analysis

Vaxart (VXRT) Convertible Debt (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,163.48 Bn 1,132.06 Bn 19.71 Bn
2 Johnson & Johnson 631.16 Bn 549.69 Bn 17.26 Bn
3 AbbVie 502.63 Bn 475.74 Bn 12.70 Bn
4 Merck 378.53 Bn 332.91 Bn 12.21 Bn
5 Novartis Ag 302.83 Bn 266.82 Bn 11.24 Bn
6 Astrazeneca 265.92 Bn 239.60 Bn 12.86 Bn
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn
10 Vaxart 114.30 Mn 50.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 35.28 Mn
API Access

Vaxart Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=VXRT&period=max&api_key=YOUR_API_KEY